General Information of the Compound
Compound ID
CP0503097
Compound Name
3-methyl-N-(4-thiazol-2-ylpiperidin-1-ylmethyl)-benzamide
    Show/Hide
Structure
Formula
C17H21N3OS
Molecular Weight
315.442
Canonical SMILES
Cc1cccc(c1)C(=O)NCN1CCC(CC1)c1nccs1
    Show/Hide
InChI
InChI=1S/C17H21N3OS/c1-13-3-2-4-15(11-13)16(21)19-12-20-8-5-14(6-9-20)17-18-7-10-22-17/h2-4,7,10-11,14H,5-6,8-9,12H2,1H3,(H,19,21)
    Show/Hide
InChIKey
ATPINSKUJGBMGW-UHFFFAOYSA-N
Physicochemical Property
logP
3.01842
Rotatable Bonds
4
Heavy Atom Count
22
Polar Areas
45.23
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16094665
SID: 24741042
ChEMBL ID
CHEMBL220083
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01161, D(4) dopamine receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 9.8 nM
   TI
   LI
   LO
   TS